Portfolio company
Broken String Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company provides a genomics platform to map DNA breaks for cell and gene therapy developers to assess the safety of gene editing.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ori Biotech
This company develops automated manufacturing platforms for cell and gene therapy developers to scale production of advanced medicines.
Codebreaker
This company develops a synthetic biology platform generating causal genomics data to help clinicians and researchers interpret genetic variants for disease diagnosis.
PathoQuest SAS
This company provides genomic sequencing services for biosafety and quality control testing to biopharmaceutical firms developing vaccines, cell therapies and recombinant drugs.
BioSkryb
This company develops genomic amplification and sequencing systems for researchers and clinicians to analyse DNA and RNA from single cells.
Tessera
The company develops genome engineering platforms to write therapeutic DNA sequences into cells for clinicians and researchers treating genetic diseases.
JUMPCODE Genomics
This company develops CRISPR-based reagent kits that remove unwanted genetic sequences from sequencing libraries for researchers in oncology, infectious disease and basic research.
CS Genetics
This company develops instrument-free single-cell genomics kits for academic researchers and biopharmaceutical organisations to perform transcriptomics without expensive hardware.
Form Bio
This company provides a software platform using artificial intelligence to help biopharmaceutical organisations and researchers design and optimise cell and gene therapies.
